COUPLING OF MUSCARINIC ACETYLCHOLINE-RECEPTORS, M1/M3 AND M2/M4, TO PHOSPHOINOSITIDE METABOLISM AND CA2+ CHANNELS IN DNA-TRANSFECTED NG108-15 CELLS

被引:1
|
作者
HIGASHIDA, H
NODA, M
KIMURA, Y
HASHII, M
机构
关键词
D O I
10.1254/fpj.98.3_169
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The muscarinic acetylcholine receptor (mAChR) is an integral membrane protein that transduces stimulus to effectors through the activation of guanine nucleotide-binding (G) proteins. Four or more subtypes of mAChR were detected in various tissues, and their primary structures were elucidated by cloning and sequence analysis of complementary DNA. Functional differences between them existed when they were expressed in clonal culture cells. mAChRI (m1) and mAChRIII (m3) preferentially activated phosphoinositide (PI) hydrolysis and opened Ca2+-activated K+ channels followed by closure of the M (K+)-currents, while such current activities were rarely evoked by mAChRII (m2)- and mAChRIV (m4)-transformed cells. Although it has been reported that mAChRII and mAChRIV inhibited adenylate cyclase, there was little or no such inhibition by mAChRI and mAChRIII. It is known that heart and neuronal mAChR modulate voltage-sensitive Ca2+ currents, but which species of mAChR subtypes are involved has been poorly understood. Recently we identified that endogenous mAChRIV and exogenous mAChRII expressed in NG108-15 neuroblastoma-glioma hybrid cells, but not mAChRI and mAChRIII, efficiently depressed high-threshold Ca2+ currents in a pertussis toxin-sensitive manner.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [1] DISTINCT INDUCTION OF C-FOS MESSENGER-RNA IN NG108-15 CELLS TRANSFECTED WITH MUSCARINIC M1 AND M3 RECEPTORS
    TOHDA, M
    TOHDA, C
    SAKUMA, S
    HIGASHIDA, H
    NOMURA, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (02): : 169 - 176
  • [2] Acetylcholine induces Ca2+ oscillations via m3/m4 muscarinic receptors in the mouse oocyte
    Kang, D
    Park, JY
    Han, J
    Bae, IH
    Yoon, SY
    Kang, SS
    Choi, WS
    Hong, SG
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 447 (03): : 321 - 327
  • [3] CLOZAPINE IS A POTENT AGONIST AT HUMAN M4 MUSCARINIC RECEPTORS AND AN ANTAGONIST AT M1, M2, M3, AND M5 RECEPTORS
    LISTON, D
    WARD, KM
    JONES, SB
    ZORN, SH
    LIFE SCIENCES, 1995, 56 (11-12) : 1018 - 1018
  • [4] Acetylcholine induces Ca2+ oscillations via m3/m4 muscarinic receptors in the mouse oocyte
    Dawon Kang
    Jae-Yong Park
    Jaehee Han
    In-Ha Bae
    Sook-Young Yoon
    Sang Soo Kang
    Wan Sung Choi
    Seong-Geun Hong
    Pflügers Archiv, 2003, 447 : 321 - 327
  • [5] Paradoxical sleep in mice lacking M3 and M2/M4 muscarinic receptors
    Goutagny, R
    Comte, JC
    Salvert, D
    Gomeza, J
    Yamada, M
    Wess, J
    Luppi, PH
    Fort, P
    NEUROPSYCHOBIOLOGY, 2005, 52 (03) : 140 - U10
  • [6] M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder
    Cabadak, Hulya
    Cuadra, Adolfo E.
    El-Fakahany, Esam E.
    Kan, Beki
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2009, 29 (01) : 63 - 66
  • [7] M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord
    Hoglund, AU
    Baghdoyan, HA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (01): : 470 - 477
  • [8] GENOTYPIC M3-MUSCARINIC-RECEPTORS PREFERENTIALLY INHIBIT M-CURRENTS IN DNA-TRANSFECTED NG108-15 NEUROBLASTOMA X GLIOMA HYBRID-CELLS
    ROBBINS, J
    CAULFIELD, MP
    HIGASHIDA, H
    BROWN, DA
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1991, 3 (08) : 820 - 824
  • [9] Interaction of edrophonium with muscarinic acetylcholine M2 and M3 receptors
    Tanito, Y
    Miwa, T
    Endou, M
    Hirose, Y
    Gamoh, M
    Nakaya, H
    Okumura, F
    ANESTHESIOLOGY, 2001, 94 (05) : 804 - 814
  • [10] Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse
    Tran, John A.
    Matsui, Minoru
    Ehlert, Frederick J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02): : 649 - 656